Medi-Tech Insights

The global precision medicine software market is driven by the growing research in the field of genomics/precision medicine, significant VC fundings, rising government support and initiatives and rapid shift toward personalized treatments.

Rising number of amniotic membrane transplantations, increasing research in stem cell & regenerative medicines, rising number of traumatic wounds & growing usage of dehydrated amniotic membranes are driving the global amniotic products market.

The renal denervation market growth is driven by the rising geriatric population, growing prevalence of hypertension, and venture capital fundings. The US renal denervation market is likely to offer high growth opportunities in the next 3-5 years.

Rise in surgical procedures, growing cases of trauma, technological innovations in hemostats, shrinking blood supply/donor pool in several countries and growth opportunities in emerging markets are the key factors driving the global hemostats market.

Increasing adoption of CTMS in clinical trials, higher integration of CTMS with other systems, surge in clinical trial outsourcing, investments by biotech & pharma firms & government support are driving the clinical trial management system market.

Rapid decentralization of pharmacies, rising demand to minimize medication errors, increased demand for faster prescription processing and technological advancements for improving pharmacy workflow are driving the global pharmacy automation market.

Growing prevalence of cancer, rising preference for non-invasive therapies, awareness regarding liquid biopsy and technological advancements in cancer diagnosis using liquid biopsy are some of the key factors driving the global liquid biopsy market.

Rising demand for eco-friendly surface disinfectant products, prevalence of hospital-acquired infections, awareness on personal hygiene & sanitization & implementation of stringent regulations in medical are driving the surface disinfectant market.

Favorable reimbursement of sleep apnea devices, increasing awareness about the ill-effects of untreated sleep apnea, availability of funding/grants to revolutionize diagnosis & treatment for OSA are driving the global sleep apnea devices market.

Growing adoption by pharmaceutical, medical device companies & CROs, formation of industry stakeholder groups, favorable funding & regulatory outlook and surge in M&A activities are the key factors driving decentralized clinical trials market growth.